Skip to search formSkip to main contentSkip to account menu

belimumab

Known as: Immunoglobulin G1, anti-(Human Cytokine BAFF) (Human Monoclonal LymphoStat-B Heavy Chain), Disulfide with Human Monoclonal LymphoStat-B lambda-chain, Dimer 
A fully human IgG1 monoclonal antibody directed against B-Lymphocyte stimulator protein (BlyS or TNFSF13B) with potential immunomodulating activity… 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (2)

Antibodies, Monoclonal, HumanizedImmunosuppressive Agents

Narrower (2)

BenlystaLymphoStat-B
Decreased Immunologic Activity [PE]antigen bindingbelimumab 120 MG Injection [Benlysta]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
AB0566 Anti-phospholipid antibodies sero-negativization in systemic lupus erythematosus patients treated with belimumab
Background Belimumab is a monoclonal antibody that blocks the B lymphocyte stimulator, preventing it to bind its receptor on B… 
2018
2018
Изучение иммуногенности и безопасности 23-валентной полисахаридной пневмококковой вакцины у больных системной красной волчанкой
Objective: to investigate the safety and immunogenicity of 23-valent polysaccharide pneumococcal vaccine (PPV-23) in patients… 
2016
2016
Treatment of SLE and Secondary Sjogren’s Syndrome with Belimumab
Belimumab neutralizes the soluble form of B-cell activating factor and is FDA-approved for treating Systemic Lupus Erythematosus… 
Review
2015
Review
2015
Updating the clinical evidence on belimumab role modulating B-cell response and treatment of systemic lupus erythematosus
Treatment of patients with systemic lupus erythematosus (SLE) is still a challenge for many physicians and often associated with… 
2014
2014
Belimumab Pregnancy Registry: Prospective Cohort Study of Pregnancy Outcomes
INTRODUCTION: Systemic lupus erythematosus (SLE) is an autoimmune disorder typically affecting women of childbearing age, making… 
2014
2014
AB0494 Early Clinical Experiences with Belimumab in Polish Patients with Systemic Lupus Erythematosus
Background Belimumab is a monoclonal antibody, inhibitor of soluble B-cell activating factor, that is used in the adjuvant… 
2013
2013
Belimumab. No tangible efficacy but a risk of immunosuppression.
  • Prescrire international
  • 2013
  • Corpus ID: 41950390
Systemic lupus erythematosus is a chronic inflammatory autoimmune disease with variable clinical manifestations, mainly affecting… 
2011
2011
After half-century's wait, approval paves path for new lupus drugs
Review
2011
Review
2011
Targeting the BLyS family in autoimmunity: a tale of mouse and man
Members of the B-lymphocyte stimulator (BLyS) family play key roles in B-lymphocyte survival, selection, and differentiation… 
1984
1984
The Clinical Management of Systemic Lupus Erythematosus
1 Brewerton D A. HLA-B27 and the inheritance of susceptibility to rheumatic diseases. Arthritis Rheum 1976; 19: 656-68. 2 Masi A… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)